View Older Stories View More Recent Stories

May 29, 2025 08:00AM Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%
May 22, 2025 08:00AM Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner
May 21, 2025 03:18PM Ainos (AIMD) signs commercial media agreement with New to The Street
May 21, 2025 02:20PM AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street
May 19, 2025 08:00AM Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy
May 14, 2025 08:00AM Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors
May 13, 2025 07:46AM Ainos (AIMD) Misses Q1 EPS by 21c
May 12, 2025 08:00AM Ainos Reports First Quarter 2025 Financial Results
May 2, 2025 09:00AM Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Apr 30, 2025 08:12AM Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing
Apr 23, 2025 08:00AM Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly
Apr 21, 2025 08:04AM Ainos (AIMD) and ugo Complete First Robotic Smell Integration in Japan
Apr 21, 2025 08:00AM Ainos and ugo Complete First Robotic Smell Integration in Japan
Apr 14, 2025 08:00AM Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
Apr 11, 2025 08:00AM Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling
Mar 24, 2025 05:00PM Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025
Mar 13, 2025 09:00AM Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More
Mar 11, 2025 09:03AM Ainos (AIMD) and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
Mar 11, 2025 09:00AM Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
Mar 7, 2025 04:45PM Ainos Reports Full Year 2024 Financial Results
Mar 7, 2025 01:30PM Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here
Mar 5, 2025 10:04AM Ainos (AIMD) and ugo to Develop a Robot With a Sense of Smell
Mar 5, 2025 10:00AM Ainos and ugo to Develop the World's First Robot With a Sense of Smell
Jan 27, 2025 10:02AM Ainos (AIMD) Receives Japan Patent Approval for VELDONA Redefines Antiviral Innovation
Jan 27, 2025 10:00AM Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation
Jan 21, 2025 10:00AM Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025
Jan 17, 2025 09:02AM Ainos (AIMD) Granted Nasdaq Extension to Regain Compliance
Jan 17, 2025 09:00AM Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
Jan 13, 2025 10:00AM Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots
Dec 23, 2024 06:26AM Ainos (AIMD) Files for 6.74M Share Offering by Selling Stockholders
Dec 18, 2024 12:05PM CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
Dec 18, 2024 08:00AM Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
Dec 13, 2024 08:00AM Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement
Dec 4, 2024 08:00AM Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing
Dec 2, 2024 08:00AM Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug
Nov 13, 2024 08:00AM Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments
Nov 11, 2024 08:00AM Ainos Announces IRB Approval for Sjögren’s Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 20
Nov 8, 2024 08:02AM Ainos (AIMD) Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities
Nov 8, 2024 08:00AM Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities
Nov 6, 2024 04:30PM Ainos Reports Third Quarter 2024 Financial Results
Oct 28, 2024 08:00AM Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets
Oct 24, 2024 10:50AM Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast
Oct 7, 2024 08:00AM Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies
Sep 25, 2024 08:03AM Ainos (AIMD) Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial
Sep 25, 2024 08:00AM Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA
Sep 24, 2024 10:55AM Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome
Sep 23, 2024 08:09AM Ainos (AIMD) Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
Sep 23, 2024 08:00AM Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
Sep 20, 2024 08:00AM Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
Sep 17, 2024 08:09AM Ainos (AIMD) to Initiate Taiwan Clinical Study for VELDONA
View More Recent Stories View Older Stories